Article Information
History
- May 21, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Maria Gonzalez-Cao, MD1,*,
- Mónica Antoñanzas Basa, MD2,
- Teresa Puertolas, MD3,
- Eva Muñoz, MD4,5,
- José Luis Manzano, MD6,
- Cristina Carrera, MD7,
- Ivan Marquez-Rodas, MD8,
- Pilar Lopez Criado, MD9,
- Juan Francisco Rodriguez Moreno, MD10,
- Almudena García Castaño, MD11,
- Juan Martín-Liberal, MD12,
- Pedro Rodríguez-Jiménez, MD13,
- Susana Puig, MD7,
- Pablo Cerezuela, MD14,
- Marta Feito Rodríguez, MD15,
- Belén Rubio Viqueira, MD16,
- Guillermo Crespo, MD17,
- Pablo Luna Fra, MD18,
- Cristina Aguayo Zamora, MD19,
- Pablo Ayala de Miguel, MD20,
- Rosa Feltes Ochoa, MD15,
- Lara Valles, MD21,
- Ana Drozdowskyj, PhD1,
- Ainara Soria, MD22,
- Cayetana Maldonado Seral, MD23,
- Luis Fernández-Morales, MD24,
- Rafael Rosell, MD1,25,
- Mariano Provencio, MD26,
- Alfonso Berrocal, MD27,
- for the Spanish Melanoma Group (GEM).
- 1Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, Barcelona, Spain;
- 2Medical Oncology Department, Hospital Clinico San Carlos, Madrid, Spain;
- 3Medical Oncology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain;
- 4Medical Oncology Department. Hospital Universitari Vall d’Hebron, Barcelona, Spain;
- 5Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain;
- 6Catalonian Institute of Oncology (ICO-Badalona), Medical Oncology Department, Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Barcelona, Spain
- 7Dermatology Department, Melanoma Group IDIBAPS, Hospital Clinic, University of Barcelona, Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER) Spain;
- 8Medical Oncology Department, Hospital General Universitario Gregorio Marañon and CIBERONC, Madrid, Spain;
- 9Medical Oncology Department, Hospital MD Anderson, Madrid, Spain;
- 10Medical Oncology Department, Centro Integral Oncologico HM Clara Campal, Madrid, Spain;
- 11Medical Oncology Department, Hospital Marqués de Valdecilla, Santander, Spain;
- 12Medical Oncology Department, Catalan Institute Of Oncology (ICO) Hospitalet, Barcelona, Spain;
- 13Dermatology Department, Hospital Universitario La Princesa, Madrid, Spain;
- 14Medical Oncology Department, H.U. Virgen de la Arrixaca, Murcia, Spain;
- 15Hospital Universitario La Paz, Madrid, Spain;
- 16Hospital Universitario Quironsalud, Madrid, Spain;
- 17Hospital Universitario de Burgos, Burgos, Spain;
- 18Hospital Son Espases, Mallorca, Spain;
- 19Hospital Universitario Infanta Sofía, Madrid, Spain;
- 20Hospital San Pedro de Alcántara, Cáceres, Spain;
- 21Hospital General de Villalba, Madrid, Spain;
- 22Hospital Ramon y Cajal, Madrid, Spain;
- 23Hospital Universitario Central de Asturias, Oviedo, Spain;
- 24Parc Tauli Hospital Universitario,Barcelona, Spain;
- 25Germans Trias i Pujol Research Institute and Hospital (IGTP), Badalona, Spain;
- 26Hospital Puerta de Hierro, Madrid, Spain;
- 27Hospital Universitario General de Valencia, Valencia, Spain
- ↵*Correspondence to:
Maria Gonzalez-Cao MD, PhD, Translational Cancer Research Unit, Instituto Oncologico Dr Rosell, Dexeus University Hospital, C/Sabino Arana, 5, 080028 Barcelona (Spain), Tel: +34 93 546 0135, Email: mgonzalezcao{at}oncorosell.com